non small cell lung cancer (nsclc)

Showing 1 - 25 of 31

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)

Not yet recruiting
  • Solid Tumors With HRAS Alterations
  • +4 more
  • (no location specified)
Aug 30, 2023

Metastatic, Melanoma, Non Small Cell Lung Cancer (NSCLC) Trial in Philadelphia (Radiotherapy, MEDI4736, Tremelimumab)

Active, not recruiting
  • Metastatic
  • +4 more
  • Radiotherapy
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jan 6, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Malignant Solid Tumor, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial in Worldwide (GEN1042, Pembrolizumab,

Recruiting
  • Malignant Solid Tumor
  • +5 more
  • GEN1042
  • +8 more
  • San Diego, California
  • +27 more
Dec 24, 2022

Advanced Solid Tumors Cancer, Non Small Cell Lung Cancer (NSCLC) Trial in Worldwide (ABBV-637, Docetaxel, Osimertinib)

Recruiting
  • Advanced Solid Tumors Cancer
  • Non Small Cell Lung Cancer (NSCLC)
  • Boston, Massachusetts
  • +32 more
Dec 9, 2022

Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM) Trial in Marseille (Vinorelbine)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Malignant Pleural Mesothelioma (MPM)
  • Marseille, France
    Assistance Publique des Hôpitaux de Marseille (CEPCM)
Nov 15, 2022

Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC)

Not yet recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • +3 more
  • (no location specified)
Jul 24, 2022

Non Small Cell Lung Cancer (NSCLC) Trial in Canada, United States (Nivolumab)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Mobile, Alabama
  • +133 more
Jan 25, 2022

Non Small Cell Lung Cancer (NSCLC) Trial in United States (SPI-1620, Docetaxel)

Terminated
  • Non Small Cell Lung Cancer (NSCLC)
  • Cincinnati, Ohio
  • +4 more
Oct 8, 2021

Non Small Cell Lung Cancer (NSCLC) Trial in Toronto (FLT-PET)

Active, not recruiting
  • Non Small Cell Lung Cancer (NSCLC)
  • FLT-PET
  • Toronto, Ontario, Canada
    University Health Network
Oct 1, 2021

Non Small Cell Lung Cancer (NSCLC) Trial in Milan (Pembrolizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer (NSCLC)
  • Milan, Italy
    National Cancer Institute
Jun 8, 2021

Non Small Cell Lung Cancer (NSCLC) Trial in India (Osimertinib)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Hyderabad, India
  • +6 more
May 10, 2021

Non Small Cell Lung Cancer (NSCLC), Metastases to the Brain Trial in Pittsburgh (cabozantinib)

Terminated
  • Non Small Cell Lung Cancer (NSCLC)
  • Metastases to the Brain
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute- Hillman Cancer Center
Mar 8, 2021

Non Small Cell Lung Cancer (NSCLC) Trial in United States (Nab-Paclitaxel)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Fayetteville, Arkansas
  • +7 more
Sep 14, 2020

Non Small Cell Lung Cancer (NSCLC) Trial in Pittsburgh (semi-allogeneic human fibroblasts (MRC-5) transfected with DNA)

Terminated
  • Non Small Cell Lung Cancer (NSCLC)
  • semi-allogeneic human fibroblasts (MRC-5) transfected with DNA
  • Pittsburgh, Pennsylvania
  • +1 more
Apr 10, 2019

Non Small Cell Lung Cancer (NSCLC) Trial in Maastricht (Nitroglycerin patch)

Terminated
  • Non Small Cell Lung Cancer (NSCLC)
  • Nitroglycerin patch
  • Maastricht, Netherlands
    MAASTRO clinic
Feb 12, 2019

Non Small Cell Lung Cancer (NSCLC) Trial in Korea, Republic of, United States (Dacomitinib, Doxycycline, Probiotic)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Duarte, California
  • +80 more
Dec 20, 2018

Non Small Cell Lung Cancer (NSCLC) Trial in Chapel Hill, Pittsburgh (Bavituximab)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Chapel Hill, North Carolina
  • +1 more
Dec 3, 2018

Non Small Cell Lung Cancer (NSCLC) Trial in Worldwide (ZD1839 (Iressa))

Approved for marketing
  • Non Small Cell Lung Cancer (NSCLC)
  • ZD1839 (Iressa)
  • La Plata, Argentina
  • +64 more
Sep 12, 2018

Non Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN) Trial in Canada, United States

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • Birmingham, Alabama
  • +32 more
May 14, 2018

Renal Cancer, Non Small Cell Lung Cancer (NSCLC), Soft Tissue Sarcoma Trial in Charleston (Panobinostat (LBH589), Sorafenib)

Completed
  • Renal Cancer
  • +2 more
  • Panobinostat (LBH589), Sorafenib
  • Charleston, South Carolina
    Medical University of South Carolina Hollings Cancer Center
Feb 28, 2017

Non Small Cell Lung Cancer (NSCLC) Trial in United States (Cetuximab)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Miami, Florida
  • +30 more
Dec 7, 2016

Non Small Cell Lung Cancer (NSCLC), Intrathoracic Nodal Staging Trial in Amsterdam, Nijmegen, Krakow

Unknown status
  • Non Small Cell Lung Cancer (NSCLC)
  • Intrathoracic Nodal Staging
    • Amsterdam, Netherlands
    • +3 more
    Dec 15, 2016

    Non Small Cell Lung Cancer (NSCLC), Radical Treatment, Stage III NSCLC Trial in Netherlands (Prophylactic Cranial Irradiation)

    Completed
    • Non Small Cell Lung Cancer (NSCLC)
    • +2 more
    • Prophylactic Cranial Irradiation
    • Maastricht, Limburg, Netherlands
    • +8 more
    Apr 9, 2015